We have developed the world's first discovery of vascular-specific stem cells as cell therapy, providing groundbreaking solutions for the patients suffering from unresolved microvascular diseases.Our patented seed technology, vascular endothelial stem cells, is distributed in blood vessels throughout the body and is essential for the maintenance and regeneration of blood vessels in the body.We provide novel solutions for many microvascular diseases through two therapeutic concepts. The first is angiogenesis therapy, which can be applied to digital ulcers of systemic sclerosis, diabetic wounds, critical limb ischemia, vascular dementia, breast reconstruction, etc. The second, with angiocrine therapy, it is possible to completely cure hemophilia and lysosomal storage disorder through cell transplantation.